Cryosa raises $21.5M to further development of sleep-apnea treatment

The Arden Hills-based company is working on a minimally invasive therapy for OSA that doesn't require daily patient compliance.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.